PSU16 Retrospective Analysis of Cost Outcomes for Patients Receiving Infuse Bone Graft (rhBMP-2) or Actifuse Bone Graft Substitute (Si-CaP) During Posterolateral Spinal Fusion
Abstract
Authors
G. Magee A. Boatright E. Hagerman D. Baumer S. Krishnan